Latest Breaking News On - Pierre fabre medicament - Page 1 : vimarsana.com

Puma Biotechnology (NASDAQ:PBYI) & Shattuck Labs (NASDAQ:STTK) Critical Review

Puma Biotechnology (NASDAQ:PBYI – Get Free Report) and Shattuck Labs (NASDAQ:STTK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk. Earnings & Valuation This table compares Puma […]

United statesLos angelesGiven shattuck labPint pharma internationalShattuck labTakeda pharmaceutical companyKnight therapeutics incMedison pharma ltdPfizer incPuma biotechnology incShattuck labs incBixink therapeutics co ltdTherapeutics asia pte ltdPuma biotechnologyGet free reportShattuck labs

Financial Review: Nature s Sunshine Products (NASDAQ:NATR) and Puma Biotechnology (NASDAQ:PBYI)

Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) and Puma Biotechnology (NASDAQ:PBYI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Insider & Institutional Ownership 76.1% of […]

United statesLos angelesNature sunshine productsNature sunshine products incPfizer incTherapeutics asia pte ltdKnight therapeutics incPuma biotechnology incPint pharma internationalBixink therapeutics co ltdSunshine productsGet free reportPuma biotechnologyGiven puma biotechnologyNorth americaLatin america

Pierre Fabre Supercritical Fluids Division to Exhibit at Drug Delivery Partnerships 2016

Pierre Fabre Supercritical Fluids Division to Exhibit at Drug Delivery Partnerships 2016
pharmaceutical-technology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-technology.com Daily Mail and Mail on Sunday newspapers.

United statesPalm beachSupercritical fluidsPierre fabre medicamentDrug delivery partnershipsPalm beach gardens

Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland

Pierre Fabre Médicament SAS (Pierre Fabre) to register and commercialize vibegron for the treatment of Overactive Bladder (OAB) in the Europe Economic Area, UK, and Switzerland. Urovant Sciences

United statesUnited kingdomPierre fabreSumitovant biopharmaJim robinsonMaya frutigerEric ducournauAlana darden powellAnne kerveillantUrovant sciences gmbMedia relations pf pharmaceuticals directionCorporate communicationsPierre fabre groupUrovant sciencesSumitovant biopharma ltdHead of corporate communications

Contrasting Avalo Therapeutics (NASDAQ:AVTX) & Puma Biotechnology (NASDAQ:PBYI)

Avalo Therapeutics (NASDAQ:AVTX – Get Rating) and Puma Biotechnology (NASDAQ:PBYI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability. Valuation & Earnings This table compares Avalo Therapeutics and […]

United statesLos angelesKnight therapeutics incAvalo therapeutics incCerecor incPint pharma internationalAvalo therapeutics company profile get ratingPuma biotechnology incTherapeutics asia pte ltdBixink therapeutics co ltdPfizer incPuma biotechnology company profile get ratingAvalo therapeuticsGet ratingPuma biotechnologyGiven avalo therapeutic